Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05567744 · ClinicalTrials.gov registry record

Registry for CADASIL

A clinical trial of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
2,500
Enrollment target
1
Study location

NCT05567744 is a study of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05567744, a study of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
2,500 participants
Enrollment target
1
Study location

Study Summary

This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.

Interventions

  • OTHER Registry

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2022-06-03
Est. Completion 2027-10

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05567744

The ClinicalTrials.gov registry entry for NCT05567744 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.

NCT05567744 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05567744 about?

NCT05567744 is a clinical study titled "Registry for CADASIL". This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL o...

What is the current status of trial NCT05567744?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2022-06-03. Estimated completion is 2027-10.

What conditions does trial NCT05567744 study?

This clinical trial studies the following conditions: Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy.

What interventions are being tested in trial NCT05567744?

The interventions under investigation include: Registry (OTHER).

Who is sponsoring clinical trial NCT05567744?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05567744 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.